| Daily Health News Provided by Tenet |
| Today's Articles: Pain Management |
Category Listing >> |
DepoMorphine New Drug Application submitted to the US Food & Drug Administration.
| | SkyePharma PLC announced that on 18 Jul 2003 it submitted a New Drug Application to the US Food & Drug Administration for DepoMorphine, SkyePharma's novel sustained-release injectable formulation of morphine for control of moderate-to-severe post-operative pain. | Roche Gets Positive EU Recommendation For Bondronat -2
| | ZURICH -- Roche Holding AG Monday said the CMPC panel of the European Agency for the Evaluation of Medicinal Products, or EMEA, has issued a positive opinion for the use of oral and intravenous Bondronat in patients with breast cancer and bone metastases. | Curis Reports on Small Molecule Hedgehog Agonists
| | CAMBRIDGE, Mass. --Results from a recent study indicated that small molecule agonists of Curis Inc. | PainCare Holdings Secures Exclusive North American Distribution Rights to MedX Medical
| | New Contract To Yield Enhanced Profitability From PainCare's MedX-Direct Programs While Also Generating New Revenue Stream ORLANDO, Fla. | Advanced Neuromodulation Systems Second Quarter Net Income Doubles on 79% Increase in Neuro Product
| | DALLAS--(BUSINESS First Half Net Income Increases 143%; Management Increases Guidance for 2003 Advanced Neuromodulation Systems, Inc. announced today that revenue for the three months ended June 30, 2003, increased 66% to a record $22,324,000. | Published Study Reports NovaSure(tm) Treatment Is Much Less Painful Than ThermaChoice(tm) Treatment
| | PALO ALTO, Calif., July 28 /PRNewswire/ -- The May 2003 Journal of the American Association of Gynecologic Laparoscopists reports the results of a study demonstrating that the use of the NovaSure treatment for excessive menstrual bleeding by Novacept, Inc. |
| Category Listing >> |
| 